Results 151 to 160 of about 54,267 (309)
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
Flavia Regina Medeiros da Silva +7 more
wiley +1 more source
Health System Factors Associated With Correct use of Artemether-Lumefantrine for Management of Uncomplicated Malaria in Rural Tanzania [PDF]
Poor adherence to and inappropriate use of antimalarials leads to ineffective cure and promote development of drug resistance. We assessed quality of malaria case management in two areas with health and demographic surveillance systems in rural Tanzania ...
Amuri, Baraka +7 more
core
The private commercial sector distribution chain for antimalarial drugs in Benin - Findings from a rapid survey [PDF]
, 2009 In November 2008, the Global Fund to Fight HIV/AIDS, TB and Malaria announced that it would administer the first phase of an ambitious scheme to increase the availability of effective treatment for malaria, the Affordable Medicines Facility – malaria ...
Goodman, C +4 more
core
Tissue Resident Memory Cells: Friend or Foe?
Immunology, EarlyView.Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude +2 more
wiley +1 more source
ACTwatch 2009 Supply Chain Survey Results, DRC [PDF]
, 2012 In the DRC, as in many low‐income countries, private commercial providers play an important role in the treatment of malaria. To design effective interventions for improved access to accurate diagnosis and effective malaria treatment, there is a need to
Akulayi Tshinungu, L +7 more
core
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study
Journal of the European Academy of Dermatology and Venereology, EarlyView.Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth +8 more
wiley +1 more source
Imaging malaria parasites across scales and time
Journal of Microscopy, EarlyView.Abstract The idea that disease is caused at the cellular level is so fundamental to us that we might forget the critical role microscopy played in generating and developing this insight. Visually identifying diseased or infected cells lays the foundation for any effort to curb human pathology.
Julien Guizetti
wiley +1 more source
The potency of finding a new antimalarial drug from Indonesian sea
, 2010 Murtihapsari Murtihapsari +1 more
openalex +2 more sources